Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
For RRMM participants who have received at least one prior line of therapy (LoT) for MM:
For NDMM participants receiving frontline therapy:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria apply
Missoula, Missouri 59802, United States
No City Provided, New Jersey 00000, United States
No City Provided, New Jersey 00000, United States
No City Provided, New Jersey 00000, United States
No City Provided, New Jersey 00000, United States
No City Provided, New Jersey 00000, United States
No City Provided, New Jersey 00000, United States